APA (7th ed.) Citation

Protić-Rosić, I., Sehgal, A. N. A., Wrighton, S., Heller, B., & Pickl, W. F. (2025). Chimeric Autoantibody Receptor- and/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases. Cells (2073-4409), 14(10), 753. https://doi.org/10.3390/cells14100753

Chicago Style (17th ed.) Citation

Protić-Rosić, Isidora, Al Nasar Ahmed Sehgal, Sebastian Wrighton, Birgit Heller, and Winfried F. Pickl. "Chimeric Autoantibody Receptor- And/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases." Cells (2073-4409) 14, no. 10 (2025): 753. https://doi.org/10.3390/cells14100753.

MLA (9th ed.) Citation

Protić-Rosić, Isidora, et al. "Chimeric Autoantibody Receptor- And/or Peptide-MHC-Based CAR Therapies for Targeted Elimination of Antigen-Specific B or T Cells in Hypersensitivity Disorders Such as Allergies and Autoimmune Diseases." Cells (2073-4409), vol. 14, no. 10, 2025, p. 753, https://doi.org/10.3390/cells14100753.